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Enveloped viruses contain surface proteins that mediate fusion between the viral and target cell membranes
following an activating stimulus. Acidic pH induces the influenza virus fusion protein hemagglutinin (HA) via
irreversible refolding of a trimeric conformational state leading to exposure of hydrophobic fusion peptides on
each trimer subunit. Herein, we show that cells expressing fowl plague virus HA demonstrate discrete
switching behavior with respect to the HA conformational change. Partially activated states do not exist at the
scale of the cell, activation of HA leads to aggregation of cell surface trimers, and newly synthesized HA refold
spontaneously in the presence of previously activated HA. These observations imply a feedback mechanism
involving self-catalyzed refolding of HA and thus suggest a mechanism similar to the autocatalytic refolding
and aggregation of prions.
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1Enveloped viruses contain surface proteins that mediate fusion between the viral and target
cell membranes following an activating stimulus.  Acidic pH induces the influenza virus
fusion protein hemagglutinin (HA) via irreversible refolding of a trimeric conformational
state leading to exposure of hydrophobic fusion peptides on each trimer subunit.  Herein,
we show that cells expressing fowl plague virus HA demonstrate discrete switching
behavior with respect to the HA conformational change.  Partially activated states do not
exist at the scale of the cell, activation of HA leads to aggregation of cell surface trimers,
and newly synthesized HA refold spontaneously in the presence of previously activated HA.
These observations imply a feedback mechanism involving self-catalyzed refolding of HA
and thus suggest a mechanism similar to the autocatalytic refolding and aggregation of
prions.
Keywords: cooperative activation, HA, hemagglutinin, influenza, autocatalysis
Abbreviations used:  HA, hemagglutinin; FPV, fowl plague virus; DTT, dithiothreitol; IRES,
internal ribosome entry site; CMV, cytomegalovirus
2Membrane fusion is an important step in many biological activities, and numerous studies
have been performed to investigate fusion protein function1-4.  Fusion protein activity is required
in all infections by enveloped viruses, including influenza viruses.  Influenza, an
orthomyxovirus, is surrounded by a lipid bilayer membrane envelope captured from the plasma
membrane of the cell that generated it, and infection of a host cell involves binding to cell
surface sialic acid-containing glycoproteins followed by internalization into endosomal vesicles.
Thus, two membranes (viral and endosomal) separate the viral genome from the cell cytoplasm.
Viral genetic material is passed through these barriers to the cytosol by fusion of the viral and
endosomal membranes, a thermodynamically unfavorable process in the absence of additional
energy release5.  Fusion is promoted by the HA protein, which undergoes a dramatic, irreversible
conformational rearrangement following exposure to the low pH of the acidified endosome6.
Viral fusion proteins, including HA, contain highly conserved hydrophobic peptide segments of
~20 amino acids that are essential to fusion activity1, 6.  Current models suggest that these fusion
peptides spontaneously insert into either the target or viral membrane upon exposure3, and, along
with other conformational alterations of the protein, disrupt membrane structure to allow fusion.
HA is a homotrimer of heterodimer subunits; each HA subunit is synthesized as a single
polypeptide (HA0) and proteolytically cleaved into disulfide-linked HA1 and HA2 subunits7-9.
The x-ray crystal structures of neutral pH (inactive) and pH-activated HA fragments indicate that
the fusion peptide relocates from a site largely buried within the trimer to the membrane-distal
end of the structure upon activation6, 10.  Experimental evidence indicates this refolding pathway
contains reversible intermediate steps10-13, and cooperative interaction among adjacent trimers is
believed to promote the irreversible transition to the final fusion-competent, refolded state14-18.
These observations are consistent with the putative requirement for synchronized energy release
3via conformational change of multiple HA trimers to overcome the thermodynamic barrier to
membrane fusion5.
Assay of HA refolding decoupled from membrane fusion
We have developed a mammalian expression system where the conformational change of
HA from the H7N1 antigenic subtype fowl plague virus A/FPV/Rostock/34 (FPV), can be
detected easily and quantitatively by immunofluorescence.  A ten amino acid epitope tag
sequence (c-myc) was substituted for the C-terminal half of the 20 amino acid FPV fusion
peptide (Figure 1a and b), thereby generating a presumably nonfusogenic mutant HA (designated
HA3.1) with a conveniently detectable tag potentially sensitive to the activation state of the
protein.  Cell surface HA (both tagged mutant and wild-type) expressed on transiently
transfected NIH-3T3 fibroblasts was analyzed by flow cytometry.  Immunofluorescent staining
with an anti-HA1 monoclonal antibody demonstrated indistinguishable expression levels of the
HA3.1 mutant and wild-type HA (data not shown).  The mutant HA also showed irreversible,
pH-induced exposure of the epitope tag indistinguishable from pH-induced activation of wild-
type HA (Figure 1c), and pH-activated mutant HA were quantitatively sensitive to thermolysin
digestion (0.1 mg/mL), which removes the first 23 residues of the HA2 subunit19, and reduction
of the HA1-HA2 intrachain disulfide bond (data not shown).  Non-activated mutant HA were
insensitive to thermolysin or DTT, consistent with the behavior of wild-type HA from various
influenza strains17.  Two alternative mutants constructed with the epitope tag in the first 11
fusion peptide residues expressed but failed to demonstrate c-myc tag exposure at any tested pH
(data not shown), possibly due to inhibition of proteolytic cleavage of the HA0 form, the
necessity of fusion peptide residues 1 - 11 in the activation, or perturbation of interactions
4between these residues and the charged pocket of the HA1 subunit20.  Varying the pH of the
activating pulse applied to the cells yielded transitions dependent upon the length of the pulse, as
expected for an irreversible process (Figure 1c).
Cell-scale synchronization of HA activation
Surprisingly, we observed that transfected cells subjected to pH pulses in the transition
region (i.e., partially activated states of the system) demonstrate a strict bimodal response at the
cell population level in the case of both tagged mutant and wild-type HA (Figure 1d - g).  While
fewer cells are activated by higher pH pulses, cell response is rigorously two-state; the
intermediate states of the system (i.e., cells activated at intermediate pH or for intermediate
duration) include no cells with intermediate levels of c-myc epitope exposure or loss of HC58
reactivity, but rather a mixture of cells with fully non-activated or fully refolded HA.  In
addition, no cells are positive for both c-myc tag exposure and preinduction conformation
(Figure 1g).  Thus, no cell exists in a state in which only a fraction of its inducible HA trimers
have proceeded through the irreversible conformational change.  This striking result indicates
that individual cells reach a critical threshold beyond which all activation-competent HA trimers
on the cell are irreversibly committed to refolding, implying either cooperative activity on a
massive scale or an alternative mechanism such as autocatalysis is involved in the refolding
pathway.
Density dependence of HA refolding
Concerted activation of FPV HA proceeding to completion following reversal of the pH
pulse implies intertrimer interactions and thus a dependence on trimer cell surface density.  To
5further investigate this phenomenon, we quantitatively analyzed density dependence using the
flow cytometric data of Figure 1e - f.  As the acidity or duration of the activating pulse increased,
cells with decreasing levels of surface-expressed HA were activated (Figure 1e - f and Figure 2),
consistent with the behavior of HA from other antigenic subtype strains as observed via bulk
biochemical assays16, 17, 21, which yield data averaged over cell or virus populations.  Analysis of
activation lag times as a function of surface expression density suggests lag time converges to
~2.5 min at high HA density (Figure 2c).
Activation-induced HA aggregation
The pre- and post-activation spatial localization of FPV HA were examined by
fluorescence microscopy (Figure 3).  Cells expressing either wild-type or c-myc-tagged FPV HA
demonstrate distributed anti-HA staining prior to an activating pulse, while acid-pulsed cells
demonstrate substantial aggregation of HA.  Thus, pH-induced refolding of HA appears to
coincide with aggregation of refolded trimers, in agreement with previous observations of pH-
induced morphological alteration and mobility restriction of HA from another influenza strain5, 19,
22.  HA3.1-expressing cells activated at intermediate pH and costained for both HA3.1 protein
and exposed c-myc tag demonstrate the expected discrete activation phenomenon, and exposed
c-myc tags co-localize with aggregated HA3.1 protein (Figure 3c).  In accord with flow
cytometry data, partially activated cell populations show cells positive for either aggregated and
exposed c-myc tags or distributed and nonrefolded HA3.1, with no coincidence of the two
phenotypes (Figure 3d).
6Autocatalytic refolding of HA dependent on fusion peptide
What mechanism might explain the observed phenomena?  Intertrimer cooperativity
leading to tandem refolding of trimer aggregates is consistent with density dependence; however,
this model predicts that partially-induced intermediate states, in which only a fraction of
cooperative units on a given cell are refolded, should exist at the cell scale assuming the
cooperative unit is smaller than the number of trimers expressed.  We observe no such
intermediate states in a large statistical sampling by flow cytometry, as indicated by the lack of
intermediate cell populations demonstrating c-myc staining decorrelated from expression level
(Figure 1d-f).  The absence of partially activated cellular intermediates would thus suggest that
the minimal cooperative unit contains all trimers on the cell surface; however, this model then
raises the question as to how the cooperative unit could vary dramatically between two cells
expressing HA at levels differing by >10-fold, as seen here (e.g., Figure 1e).  We observe no
stable (i.e., equilibrated) cell populations where high expressers are activated while those of low
expression density are not, suggesting the critical cooperative unit size must be less than the
minimum observable trimer expression level in the transfected cell population.  Our observation
that refolding of FPV HA trimers on a cell proceeds irreversibly to a fully activated state,
regardless of expression density, therefore argues that cooperative activation cannot fully explain
the phenomenon.
The simplest model consistent with these data includes a positive feedback mechanism by
which irreversibly activated FPV HA trimers (which may result from an event involving a small
cooperative unit) promote the irreversible refolding of non-activated trimers (Figure 4a).  This
model accounts for the observed irreversible commitment to refolding at the cell scale; once one
7or more trimers become irreversibly refolded, the feedback chain reaction proceeds until all
remaining activatable trimers have refolded, despite removal of the activating pH stimulus.
To more directly test this model, we pulsed cells expressing low levels of HA prior to
further culturing to allow synthesis and secretion of additional HA that had not been exposed to
the inducing low pH pulse.  At both 8 h (Figure 4b, c) and 20 h (data not shown) after the
inducing pH pulse, HA3.1-expressing cells demonstrated increased HA levels and a correlated
increase in c-myc tag exposure.  Similarly, wild-type HA-expressing cells demonstrated
increased HA levels 8 h after an inducing pH pulse, yet the new HA failed to react with trimer-
specific mAb HC58 (Figure 4e), indicating it had adopted the activated conformation.  Thus,
new HA expressed during the post-pulse culturing refolded spontaneously, supporting the model
that refolding was catalyzed by the previously refolded HA already present on the cell.
Furthermore, treatment of pH-pulsed cells with thermolysin prior to reculturing quantitatively
cleaved the fusion peptide/c-myc tag region and abolished spontaneous refolding of newly
synthesized HA (both HA3.1 and wild-type HA), while the new HA remained inducible by a
subsequent acid pulse (Figure 4d, e).  In contrast, trypsin treatment (20 µg/mL, 15 min at 37 °C)
of pH pulsed cells (which is expected to cleave the HA1 domain19) had no effect on spontaneous
HA3.1 refolding following an additional 8 h in culture (data not shown).  FPV HA was
previously shown to refold in the acidic Golgi compartment when expressed in CV-1 cells, and
this refolding was inhibited by acidotropic agents such as amantidine and NH4Cl23, which
buffered the intracellular pH.  The formal possibility therefore exists that pH pulsing 3T3 cells
might alter intracellular pH to induce HA refolding several hours later, and that thermolysin
might inhibit this effect in some manner.  Repeating experiments with 3T3 cells maintained in
the presence of 10 mM NH4Cl at all stages except the pH 5 pulse, however, yielded results
8identical to those of Figure 4c (data not shown), suggesting alteration of intracellular pH is not
responsible for the phenomenon.  Taken together, these data suggest that the fusion peptide
region, and perhaps its effect on the local membrane environment, is necessary for autocatalytic
refolding.
Autocatalysis of HA refolding could result from either direct trimer-trimer interaction or
from effects mediated by locally altered membrane structure and tension.  Either mechanism
suggests the necessity of physical interaction or proximity between refolded and nonrefolded
trimers and thus is consistent with the observed activation-correlated aggregation (Figure 3).
The relative timing of aggregation versus irreversible refolding, however, has yet to be
determined for this system, and thus a direct link between autocatalytic refolding and
aggregation has not been established.  Nonetheless, it is conceivable that trimer refolding could
be linked to incorporation into a central protein aggregate or an expanding ring of perturbed
membrane structure.  The speculation that altered membrane tension might induce refolding is
consistent with the membrane destabilization required to induce fusion with a juxtaposed target
membrane and has been previously proposed17.  This mechanism would coordinate
conformational energy release of a large number of HA trimers and lead to a domain of high-
energy membrane structure.  Indeed, a similar mechanism involved in HA-mediated membrane
fusion has been previously suggested5, and Leikina, et al., recently demonstrated that HA trimers
from outside the intercellular contact zone are necessary for fusion pore expansion24, consistent
with a requirement for activated HA aggregation.  Insertion of exposed fusion peptides into the
cell membrane (or N-terminal 11 residues of the fusion peptide in the HA3.1 mutant) could alter
membrane tension and curvature with resulting effects on trimer conformational stability;
membrane tension has been previously observed to impact folded stability of bacterial outer
9membrane protein A25.  This supposition is also consistent with the suggested structure of
membrane-embedded HA fusion peptide26-29, in which the N-terminal portion of the fusion
peptide embeds into the nonpolar membrane core and disrupts lipid structure.  However, despite
the observed thermolysin sensitivity of the autocatalytic refolding, direct evidence for membrane
involvement in this phenomenon and for the existence of autocatalytic HA refolding in the
context of intermembrane fusion require further studies.
Prion-like refolding behavior
Our proposed model for refolding of FPV HA to the fusion-active conformation parallels
the hypothesized refolding feedback mechanism by which infectious proteins (prions) induce
irreversible refolding and aggregation of structural isoforms30, and the fusion peptide of HA
demonstrates sequence similarity to amyloid β  peptide and a prion sequence31-33.  To our
knowledge, this is the first example of data consistent with such a mechanism for conformational
regulation putatively involved in the function of a membrane protein.  Whether this phenomenon
applies to other viral fusion proteins, or to other membrane proteins functionally dependent upon
conformational changes, remains to be investigated.  Nonetheless, the existence of autocatalytic.
pH-induced refolding of FPV hemagglutinin raises interesting possibilities regarding the
understanding of conformational molecular switches.
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Figure Captions
Figure 1.  Functional analysis of wild-type and HA3.1 mutant hemagglutinin and density
dependence of c-myc induction.  (a) The c-myc epitope tag sequence (underlined) replaced a
10 amino acid sequence of the fusion pepide.  A Kozak sequence GCCACC was added to the
wild-type FPV HA gene34 (from A/FPV/Rostock/34) by PCR in order to increase the expression
in mammalian cells.  Amino acids 343 to 352, 344 to 353, or 353 to 362 (i.e., fusion peptide
residues 1 - 10, 2 - 11, or 11 - 20) were replaced with the c-myc epitope tag sequence via PCR
using a SalI site introduced by a silent mutation just upstream of the fusion peptide region.
Wild-type HA and the mutants were cloned into a pIRES (BD Biosciences, Mountain View, CA)
based mammalian expression vector containing the CMV promoter after the IRES sequence was
removed.  (b) Structural rendering of X-31 HA (homologous to FPV HA) highlighting the
location of the fusion peptide in the preactivation conformation.  Fusion peptide residues 1 - 10
are colored blue and 11 - 20 (mutated in HA3.1) are colored red.  Coordinates used in the
analysis are from PDB file 1HGF35, and the images were generated using MacPyMOL software
(http://www.pymol.org).  (c) Cells were transfected using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA) following the manufacturer’s protocol.  For negative control experiments, one
well was transfected with empty pIRES vector.  Transfection efficiency was monitored by
parallel transfection with gWiz-GFP (Gene Therapy Systems, San Diego, CA).  Adherent,
nonconfluent HA3.1 (filled symbols) or wild-type HA (open symbols) vector transient
transfectants (24 h post-transfection) were pH-pulsed for 2 min or 5 min at room temperature.
HA3.1 cells were double-stained with rabbit polyclonal anti-FPV HA and anti-c-myc mAb 9E10
(Covance, Berkeley, CA), and wild-type HA cells were double-stained with biotinylated anti-
HA1 mAb HC2 and conformation-specific anti-HA1 mAb HC58 (specific for trimeric HA1 in
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the preactivation conformation)36.  HC2 mAb was purified from ascites fluid using Protein G-
agarose (Invitrogen, Carlsbad, CA) and biotinylated using the EZ-Link NHS-PEO4-Biotinylation
Kit (Pierce, Rockford, IL) following the manufacturer’s protocol.  Only viable cells, as
determined by propidium iodide exclusion and/or light scattering, were included in the analysis
by flow cytometry, and 20,000 gated events were analyzed for all flow cytometric experiments.
The fraction of HA3.1-expressing cells positive for the c-myc epitope or the fraction of wild-type
HA-expressing cells negative for HC58 is shown.  Data represents averages of four independent
experiments and error bars represent standard deviation.  (d) Wild-type HA-expressing cells
(WT HA) were pulsed at the indicated pH for 5 min at room temperature, washed with pH 7.4
buffer, co-stained with biotin-HC2 and HC58, and analyzed by flow cytometry.  Fractions of the
total viable cell population falling within the indicated regions of the two-color histograms are
indicated.  (e) HA3.1-expressing cells were pulsed at the indicated pH for 5 min or (f) pulsed at
pH 5.0 for the indicated time at room temperature and costained with rabbit anti-HA and anti-c-
myc.  (g) HA3.1-expressing cells were pulsed at the indicated pH for 5 min at room temperature,
costained with HC58 and chicken anti-c-myc (Jackson ImmunoResearch Laboratory, West
Grove, PA), and analyzed by flow cytometry.
Figure 2.  Expression density dependence of HA induction.  Flow cytometry data were gated
at various levels of anti-HA staining intensity (minimum region width set to maintain at least 100
gated events for all data points) using CellQuest software (Becton-Dickinson, Franklin Lakes,
NJ) to allow calculation of (a) the fraction of cells induced as a function of relative HA
expression density for pulse durations of 0 min (), 3.0 min (❇), 3.5 min (), 4.0 min (▲) and
4.5 min (●), or (b) the fraction of cells induced as a function of pulse time for HA expression
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densities at normalized mean fluorescence intensities of 2.28 (◆), 25.85 (●), 80.33 (■) and
204.43 (▲).   A dose-response equation was fit to the data with two adjustable parameters (pulse
time required for 50% of the cell population to be induced [T50] and inflection slope).  The
minimum R2 value of the fitted curves was 0.9875.  (c) T50 values calculated from three separate
experiments were averaged and plotted as a function of relative HA expression density.  Vertical
error bars represent standard deviation of the three values and horizontal error bars represent
standard deviation of the average corrected MFL of cells within a density gate from three
experiments.  Absence of error bars indicates range is less than the width of the symbol.  The
mean fluorescence intensity (MFL) for each gate was corrected by subtracting the mean
background auto-fluorescence intensity of a stained negative control population.
Figure 3.  Aggregation of HA following pH pulse.  (a) Live HA3.1-expressing or wild-type
HA-expressing fibroblasts were immunofluorescently stained with anti-c-myc antibody (HA3.1)
or anti-HA serum (WT HA) following a 5 min pulse at pH 5.0 and room temperature and
analyzed at 20X magnification on a Nikon ECLIPSE ES300 inverted fluorescence microscope.
(b) HA3.1 or wild-type HA-expressing cells were stained with anti-HA serum following a 5 min
pulse at the indicated pH and room temperature and analyzed at 64X magnification on an
Olympus IX71 inverted fluorescence microscope.  (c) HA3.1 expressing cells were costained
with anti-c-myc/goat anti-mouse-TRITC (red) followed by biotin-HC2/streptavidin-FITC (green)
following a 5 min pulse at pH 5.4 (room temperature) and analyzed at 40X magnification on an
Olympus IX71 inverted fluorescence microscope.  FITC and TRITC fluorescence images were
overlayed using NIH ImageJ v1.36 (http://rsb.info.nih.gov/ij/).  (d) Cells were pulsed at pH 5.4
for 5 min at room temperature 24 h post-transfection, costained with biotin-HC58/streptavidin-
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FITC (BD Biosciences, San Diego, CA) and 9E10/anti-mouse-TRITC (Sigma, St. Louis, MO) ,
and analyzed as in (c).
Figure 4.  Fusion peptide-dependent autocatalytic refolding.  (a) A possible refolding
reaction pathway for FPV HA is diagrammed.  Acidic pH-activated, refolded HA catalyzes
refolding of non-activated HA directly or through alteration of lipid bilayer structure and
membrane tension.  Steps in the shaded region represent putative intermediates suggested in
studies of X-31 HA12-15 and include exposure of the fusion peptide and clustering into
cooperative units (however, reversible intermediates have not been demonstrated for HA from
FPV).  Cooperative units might include both "primed" and inactive trimers.  Data herein implies
a positive feedback loop (i.e., an alternative product-catalyzed reaction pathway) must be active
regardless of intermediate states in the conformational change.  (b-d) HA3.1-transfected cells
were analyzed by flow cytometry 16 h (at which time cells express low but detectable levels of
HA3.1) or 24 h (high expression) after transfection.  Filled grey histograms represent empty
vector-transfected cells.  (b) Cells pulsed at 16 h post-transfection and recultured for an
additional 8 h were stained with HC2 mAb and analyzed by flow cytometry to confirm increased
expression of HA3.1 following reculturing.  (c) Cells were pulsed at pH 5.0 at 16 h post-
transfection.  A fraction of the cells were immediately labeled with anti-c-myc antibody and
analyzed by flow cytometry.  Remaining cells were cultured for an additional 8 h in fresh
medium prior to antibody staining and analysis with (P: +) or without (P: -) an additional pH 5
pulse at 24 h post-transfection.  (d) Cells pH-pulsed at 16 h post-transfection as in (c) were
treated with (T: +) or without (T: -) thermolysin (0.1 mg/mL for 30 min at 37 °C; EMD
Biosciences, San Diego, CA) to cleave the fusion peptide and a fraction analyzed by anti-c-myc
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staining and flow cytometry.  Remaining cells were cultured for an additional 8 h prior to
staining and analyzed with (P: +) or without (P: -) an additional pH pulse at 24 h post-
transfection.  (e) Cells transfected with wild-type HA vector were treated as in (c) and (d) and
analyzed using mAb HC58 specific for nonrefolded HA and mAb HC2 specific for total HA
protein to confirm autocatalytic and thermolysin-sensitive refolding of WT protein.
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